Alexander Gettler Taking inspiration from New York Times columnist David Brooks and his annual Sidney Awards for the best magazine essays of the preceding year, TPR is proud to present its Alexander Awards for the best toxicology writing on the web in 2011. The awards are named after Alexander Gettler, who was New York City’s chief […]

CONCLUSIONS  Office-based bup/nx for clinically stable patients may be a cost-effective alternative to no treatment at a threshold of $100,000/QALY depending on assumptions about quality-of-life weights. Additional research about quality-of-life benefits and broader health system and societal cost savings of bup/nx therapy is needed. Content Type Journal ArticleCategory Original ResearchPages 1-8DOI 10.1007/s11606-011-1962-8Authors Bruce R. Schackman, Department […]

Updated Date: Jan 18, 2012 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

This paper traces the early 21st century success of the agonist–antagonist buprenorphine and the combination drug buprenorphine with naloxone within the broader quest to develop addiction therapeutics that began in the 1920s as the search for a nonaddictive analgesic. Drawing on archival research, document analysis, and interviews with contemporary actors, this paper situates the social […]